| 000 | 01700 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513211353.0 | ||
| 264 | 0 | _c20000718 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0304-3835 | ||
| 024 | 7 |
_a10.1016/s0304-3835(00)00404-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, C L | |
| 245 | 0 | 0 |
_aEnhanced hydroxychavicol-induced cytotoxic effects in glutathione-depleted HepG2 cells. _h[electronic resource] |
| 260 |
_bCancer letters _cJul 2000 |
||
| 300 |
_a29-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a8-Hydroxy-2'-Deoxyguanosine |
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 | _aAntimetabolites, Antineoplastic |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aButhionine Sulfoximine _xpharmacology |
| 650 | 0 | 4 |
_aCatalase _xmetabolism |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDNA _xmetabolism |
| 650 | 0 | 4 |
_aDNA Fragmentation _xdrug effects |
| 650 | 0 | 4 |
_aDeoxyguanosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aElectrons |
| 650 | 0 | 4 |
_aEugenol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aMutagens |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aReactive Oxygen Species |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aChi, C W | |
| 700 | 1 | _aLiu, T Y | |
| 773 | 0 |
_tCancer letters _gvol. 155 _gno. 1 _gp. 29-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0304-3835(00)00404-3 _zAvailable from publisher's website |
| 999 |
_c10766608 _d10766608 |
||